This announcement is a separate document:
天大藥業：(I) 與上藥修訂現有持續關連交易之年度上限及(II) 與上藥重續框架協議
TIANDA PHARMA: (I) REVISION OF ANNUAL CAP FOR EXISTING CONTINUING CONNECTED TRANSACTION WITH SPH AND(II) RENEWAL OF FRAMEWORK AGREEMENT WITH SPH
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.